NA

Narjess Ayati

Narjess Ayati has held various roles in the medical field. Narjess is currently working as a Conjoint Senior Lecturer at UNSW and as a Staff Specialist at St Vincent's Health Australia. Narjess is also a Medical Researcher at the Garvan Institute of Medical Research. Previously, they served as a Nuclear Medicine Specialist and Molecular Imaging and Radionuclide Therapy Fellow at the Peter MacCallum Cancer Centre. Narjess has also worked as a Nuclear Medicine Physician at the Western Sydney Local Health District and as a Nuclear Medicine & PET Specialist at Austin Health. Prior to their work in Australia, they were an Assistant Professor at Mashhad University of Medical Sciences.

Narjess Ayati completed their high school education at Farzanegan from 1991 to 1998. Narjess then enrolled in the School of Medicine at Mashhad University of Medical Sciences and obtained their medical diploma in 2005. Following that, they pursued a post-graduate diploma/specialization in Nuclear Medicine from the School of Medicine at Mashhad University of Medical Sciences, which they completed from 2008 to 2011.

In terms of certifications, Narjess Ayati has received several notable certifications. In 2011, they obtained the Iranian Board of Nuclear Medicine certification from the Ministry of Health and Education of Iran. The following year, in 2012, they earned the European Board of Nuclear Medicine certification from the European Association of Nuclear Medicine. Additionally, in 2015, they obtained the American Board of Nuclear Cardiology certification from the American Society of Nuclear Cardiology and the Asian Board of Nuclear Medicine certification from the Asia Oceania Society of Nuclear Medicine.

Location

Sydney, Australia

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices


Garvan Institute of Medical Research

4 followers

The Garvan Institute of Medical Research has made significant breakthroughs in the understanding and treatment of disease. We are leaders in genomic and personalised medicine, use cutting-edge technology to study, prevent and treat major diseases like cancer, osteoporosis, diabetes, obesity, immonological, skeletal and neurological disease.


Industries

Headquarters

Sydney, Australia

Employees

501-1,000

Links